A detailed history of Prairie View Partners, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Prairie View Partners, LLC holds 70 shares of EXAS stock, worth $4,067. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70
Previous 70 -0.0%
Holding current value
$4,067
Previous $2,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 26, 2024

SELL
$59.06 - $75.72 $32,483 - $41,646
-550 Reduced 88.71%
70 $5,000
Q2 2023

Aug 04, 2023

BUY
$62.68 - $95.05 $34,474 - $52,277
550 Added 785.71%
620 $58,000
Q4 2021

Jan 21, 2022

BUY
$72.5 - $100.68 $5,075 - $7,047
70 New
70 $5,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Prairie View Partners, LLC Portfolio

Follow Prairie View Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prairie View Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prairie View Partners, LLC with notifications on news.